Solid Biosciences (SLDB) Tops Q2 EPS by 3c

August 14, 2019 7:30 AM

Solid Biosciences (NASDAQ: SLDB) reported Q2 EPS of ($0.76), $0.03 better than the analyst estimate of ($0.79).“We continue to execute ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found